4.4 Article

EXPRESSION OF THIOREDOXINS AND GLUTAREDOXINS IN HUMAN HEPATOCELLULAR CARCINOMA: CORRELATION TO CELL PROLIFERATION, TUMOR SIZE AND METABOLIC SYNDROME

Journal

Publisher

BIOLIFE SAS
DOI: 10.1177/039463201402700204

Keywords

hepatocellular carcinoma; thioredoxin; glutaredoxin; immunohistochemistty

Funding

  1. Bengt Ihre's foundation
  2. Swedish Cancer Society (Cancerfonden)
  3. Cancer and Allergy foundation (Cancer och Allergifonden)

Ask authors/readers for more resources

Thioredoxins (Trx) and glutaredoxins (Grx) are thiol oxidoreductases that are ubiquitously expressed, and are involved in several biological processes. The expression of thioredoxins and glutaredoxins is induced in many neoplasms, and correlates with prognosis in gallbladder and colorectal carcinoma. The aim of the present study was to examine the expression pattern of these proteins (redoxins) in hepatocellular carcinoma (HCC) and to correlate their levels with clinical features. Paraffin-embedded tissues from 25 patients resected for HCC and 15 patients resected for colorectal carcinoma (CRC) liver metastases were analyzed with immunohistochemistry. Our results showed that Trx1, Trx2 and Grx5 were upregulated in HCCs as compared to the respective surrounding liver. In comparison, almost all redoxins were upregulated in CRC liver metastases, with Trxl and Grx3 being significantly more increased in the CRC liver metastases than in the primary HCC tumors. In HCC, Trxl correlated significantly with cell proliferation, and with a trend towards increased levels with micro-vascular invasion, while expression of Trx2 decreased with tumor size. Trxl levels were lower in tumors of males, smokers, and patients with high alcohol consumption. Grx2 levels were significantly higher in patients with metabolic syndrome. In conclusion, this study illustrates specific correlations of individual redoxins to clinical features of HCC, and implicates the redoxins in the pathogenesis of HCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis

Karl Bjorkstrom, Per Stal, Magnus Holmer, Bonnie Bengtsson, Annika Staaf, Johan Hoffstedt, Hannes Hagstrom

Summary: Improving glycemic control through a personalized treatment program is associated with a reduction in liver steatosis and stiffness in persons with advanced T2D.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Endocrinology & Metabolism

Glucagon and Liver Fat are Downregulated in Response to Very Low-calorie Diet in Patients with Obesity and Type-2 Diabetes

Stephan L. Haas, Patrik Lofgren, Per Stal, Johan Hoffstedt

Summary: In obese patients with type-2 diabetes, a very low-calorie diet can significantly reduce plasma glucagon levels, decrease body weight, blood glucose, insulin, liver fat, and liver stiffness.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2022)

Meeting Abstract Oncology

Pembrolizumab (pembro) monotherapy for previously untreated advanced hepatocellular carcinoma (HCC): Phase II KEYNOTE-224 study.

Jean-Luc Van Laethem, Ivan Borbath, Mark Karwal, Chris Verslype, Hans Van Vlierberghe, Adel Kardosh, Vittorina Zagonel, Per Stal, Debashis Sarker, Daniel H. Palmer, Arndt Vogel, Julien Edeline, Stephane Cattan, Masatoshi Kudo, Ann-Lii Cheng, Sadahisa Ogasawara, Abby B. Siegel, Michael Jon Chisamore, Wang Anran, Andrew X. Zhu

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers

Hannes Hagstrom, Nelson Ndegwa, Molly Jalmeus, Mattias Ekstedt, Iris Posserud, Fredrik Rorsman, Nils Nyhlin, Daniel Klintman, Marten Werner, Hanns-Ulrich Marschall, Johan Askling, Per Stal

Summary: In Sweden, patients with HFE gene mutations were found to have an increased risk for hepatocellular carcinoma, hereditary haemochromatosis, cirrhosis, type 2 diabetes, osteoarthritis, and death during long-term follow-up, with excess mortality seen in men. No increased risk was observed for colorectal or breast cancer.

LIVER INTERNATIONAL (2021)

Article Gastroenterology & Hepatology

Serum levels of endotrophin are associated with nonalcoholic steatohepatitis

Hannes Hagstrom, Dawei Bu, Patrik Nasr, Mattias Ekstedt, Hannes Hegmar, Stergios Kechagias, Ningyan Zhang, Zhiqiang An, Per Stal, Philipp E. Scherer

Summary: The study suggests that serum endotrophin could be a valuable biomarker for diagnosing NASH in patients with NAFLD, but it is not significantly associated with detecting advanced fibrosis.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)

Meeting Abstract Oncology

Updated results for pembrolizumab (pembro) monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC) in the phase II KEYNOTE-224 study

J-L. van Laethem, I. Borbath, M. Karwal, C. Verslype, H. Van Vlierberghe, A. Kardosh, V. Zagonel, P. Stal, D. Sarker, D. Palmer, A. Vogel, J. Edeline, S. Cattan, M. Kudo, A-L. Cheng, S. Ogasawara, A. B. Siegel, M. Chisamore, A. Wang, A. Zhu

ANNALS OF ONCOLOGY (2021)

Article Oncology

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

Gontran Verset, Ivan Borbath, Mark Karwal, Chris Verslype, Hans Van Vlierberghe, Adel Kardosh, Vittorina Zagonel, Per Stal, Debashis Sarker, Daniel H. Palmer, Arndt Vogel, Julien Edeline, Stephane Cattan, Masatoshi Kudo, Ann-Lii Cheng, Sadahisa Ogasawara, Bruno Daniele, Stephen L. Chan, Jennifer J. Knox, Shukui Qin, Abby B. Siegel, Michael Chisamore, Ken Hatogai, Anran Wang, Richard S. Finn, Andrew X. Zhu

Summary: This study aimed to evaluate the efficacy and tolerability of pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) who had not received prior systemic therapy. The results showed that pembrolizumab demonstrated durable antitumor activity and a favorable safety profile in this patient population, supporting further evaluation of pembrolizumab-based regimens for HCC treatment.

CLINICAL CANCER RESEARCH (2022)

Article Gastroenterology & Hepatology

Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up

Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stal, Hannes Hagstrom

Summary: The study found that the PNPLA3 G/G genotype is associated with an increased rate of severe liver disease in patients with NAFLD, while overall mortality is not affected by any genetic variant.

LIVER INTERNATIONAL (2022)

Article Chemistry, Multidisciplinary

Development of Environmentally Friendly Biocidal Coatings Based on Water-soluble Copolymers for Air-cleaning Filters

Denisa Druvari, Ioanna Tzoumani, Zoi Piperigkou, Kyriaki Tzaferi, Dimitris Tselentis, Alexios Vlamis-Gardikas, Nikos K. Karamanos, Georgios Bokias, Joannis K. Kallitsis

Summary: Air pollution caused by pathogens has gained significant attention in recent years due to its impact on global health. In this study, researchers have developed a spray coating method to produce antibacterial air filters, effectively addressing the challenge of preventing secondary pollution in air-filtering devices. These filters exhibit strong and rapid antibacterial activity, making them promising candidates for filter coatings in air-purification devices.

ACS OMEGA (2022)

Article Nanoscience & Nanotechnology

Humidity-Responsive Antimicrobial Membranes Based on Cross-Linked Copolymers Functionalized with Ionic Liquid Moieties

Denisa Druvari, Fotini Kyriakopoulou, Georgia C. Lainioti, Alexios Vlamis-Gardikas, Joannis K. Kallitsis

Summary: Humidity-responsive materials have gained attention for various applications, but the susceptibility of poly(ionic liquid)s to microorganisms is often overlooked. This study focuses on the development of dual functional antimicrobial membranes derived from cross-linked copolymers functionalized with ionic liquids. The membranes exhibit high humidity responsiveness and effective inhibition of bacterial growth.

ACS APPLIED MATERIALS & INTERFACES (2023)

Review Gastroenterology & Hepatology

Non-alcoholic fatty pancreas disease and pancreatic exocrine insufficiency: pilot study and systematic review

Hartwig Maetzel, Wiktor Rutkowski, Nikola Panic, Amir Mari, Aleksandra Hedstrom, Paula Kulinski, Per Stal, Sven Petersson, Torkel B. Brismar, J. Matthias Lohr, Miroslav Vujasinovic

Summary: This study found that the prevalence of non-alcoholic fatty pancreas disease (NAFPD) was 85% in patients with non-alcoholic fatty liver disease (NAFLD) and 55% in the control group. However, PEI was not diagnosed in either group. A literature review identified PEI in 9-56% of NAFPD patients.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma

Robin Zenlander, Claudia Fredolini, Jochen M. Schwenk, Ingvar Ryden, Peter Pahlsson, Christian Loewbeer, Gosta Eggertsen, Per Stal

Summary: In this study, α-fetoprotein, des-gamma-carboxy prothrombin, thioredoxin reductase 1, and fibroblast growth factor 21 were identified as proteins with good discriminatory performance between hepatocellular carcinoma and cirrhosis in patients.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study

Axel Wester, Ying Shang, Per Stal, Hannes Hagstrom

Summary: This study assessed the time trends in mortality and life expectancy in patients hospitalized with alcohol-associated cirrhosis. The results showed that mortality has improved somewhat when accounting for baseline characteristics, but the loss in life expectancy remains substantial.

HEPATOLOGY COMMUNICATIONS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Variation in textural parameters of hepatic lesions during contrast medium injection

Yi-Hua Zhang, Katharina Brehmer, Anders Svensson, Gunnar Herlin, Per Stal, Torkel B. Brismar

Summary: Quantitative imaging techniques have shown the prognostic value of textural parameters for hepatocellular carcinoma (HCC). This study evaluated the reproducibility of textural parameters in HCC and hepatic tissue with different contrast medium timing, and found that the contrast medium timing does not affect the reproducibility of textural parameters. Therefore, it should not be a concern in CT texture analysis of HCC.

ACTA RADIOLOGICA (2021)

Article Gastroenterology & Hepatology

A Dynamic Aspartate-to-Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease

Fredrik Aberg, Christopher J. Danford, Maja Thiele, Mats Talback, Ditlev Nytoft Rasmussen, Z. Gordon Jiang, Niklas Hammar, Patrik Nasr, Mattias Ekstedt, Anna But, Pauli Puukka, Aleksander Krag, Jouko Sundvall, Iris Erlund, Veikko Salomaa, Per Stal, Stergios Kechagias, Rolf Hultcrantz, Michelle Lai, Nezam Afdhal, Antti Jula, Satu Mannisto, Annamari Lundqvist, Markus Perola, Martti Farkkila, Hannes Hagstrom

Summary: The dynamic AAR score provides prospective predictions for the risk of incident severe liver outcomes in the general population and helps detect advanced liver fibrosis/cirrhosis.

HEPATOLOGY COMMUNICATIONS (2021)

No Data Available